CClinicalTrials.gg
Enrolling by invitationNCT06903247Updated Nov 18, 2025

Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency

An observational study in Neurosonographic Findings of Vitamin D Deficiency, sponsored by Sanliurfa Education and Research Hospital. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-18.

Sponsored by Sanliurfa Education and Research Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during the prenatal period.

Read the detailed description

Vitamin D is a vitamin that regulates calcium and phosphorus balance in the body and plays a crucial role in bone health. Additionally, it is known to have effects on immune system functions and neurological health. Pregnancy is a period in which vitamin D requirements increase, and vitamin D deficiency can lead to various health problems. It is believed that vitamin D deficiency may have adverse effects on fetal neurological development and may be associated with certain pathological conditions during pregnancy.

Neurosonography is a critical tool for assessing the effects of prematurity, vitamin D deficiency, and other pregnancy complications on the fetus. This article will focus on the evaluation of neurosonographic findings in pregnant women with vitamin D deficiency.

02

Conditions studied

  • Neurosonographic Findings of Vitamin D Deficiency

Keywords

  • Neurosonography Vitamin D Deficiency Pregnancy
03

In context

Lead sponsor

Sanliurfa Education and Research Hospital is the lead sponsor of 23 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients presenting to the Perinatology clinic of Şanlıurfa Training and Research Hospital for routine antenatal care between 20-30 weeks of gestation will be included.

Eligibility criteria

Inclusion Criteria:Patients presenting for routine antenatal care between 20-30 weeks of gestation will be included.

Exclusion Criteria:Multiple pregnancy, preterm rupture of membranes, chorioamnionitis, placental abruption, severe fetal growth restriction, congenital fetal anomalies, preeclampsia, oligohydramnios and maternal diabetes.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
4 Months
Patient registry
Yes

Groups and cohorts

  • Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks

    Other: Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.

Interventions

  • OtherNeurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.

    Comparison of Neurosonographic Findings in Patients with and without Vitamin D Deficiency.

06

What researchers measure

Primary outcomes

  1. Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks of gestation.

    Time frame: Neurosonogram Results Performed Between 20-30 Weeks of Gestation.

07

Study locations

1 site
  • Sanliurfa Education and Research Hospital
    Sanliurfa, 63100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06903247
Lead sponsor
Sanliurfa Education and Research Hospital
Responsible party
Sponsor
First posted
Mar 30, 2025
Start date
Mar 15, 2025
Primary completion
Jun 30, 2025
Completion
Nov 30, 2025 (estimated)
Last update
Nov 18, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion